This sponsorship builds on QNB’s ongoing support of IIAQatar and reflects the Group’s broader efforts to support national priorities by fostering knowledge exchange, professional development, and responsible innovation across the business community.
About the Phase IIa Study. The Phase IIa clinical trial is a randomized, double-blind, placebo-controlled study designed to evaluate the safety, tolerability, and preliminary efficacy of AT-004 in adults with AV.
10, 2026 /PRNewswire/ -- Gyala Therapeutics, a clinical-stage biotechnology company developing innovative cell therapies for hematologic malignancies, today announced the initiation of a Phase I/IIa ...
On February 8, candidates�protested in Chennai after�many of them were not permitted to appear for the examination at the designated centre allocated for them ....
As per IIA... An IIA scientific publication shows that the NLOT is envisaged to meet the growing scientific requirements in astronomy and astrophysics ... IIA signed an MoU with Andhra govt to implement this recently.
PHASE IIA CLINICAL TRIAL ON δ-OPIOID RECEPTOR AGONIST NC-2800 IN PATIENTS WITH DEPRESSION ... This Phase IIa clinical trial will be conducted at 27 facilities in Japan, and will investigate the efficacy ...
Clearmind Medicine Announces SuccessfulCompletion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100 ... multinational Phase I/IIa trial," said Dr.